Related Experiment Video
Updated: Jan 12, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Elderly coagulation risk in a globalized world: burden, biomarkers, and management in Africa - a narrative review
1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
Insights
Aging populations face increased coagulation disorders, especially in Africa. Limited diagnostics and resources challenge the recognition and management of these critical conditions in the elderly.
Area of Science:
- Gerontology
- Hematology
- Public Health in Africa
Background:
- Global life expectancy increases, highlighting age-related health issues.
- Coagulation disorders are a major cause of illness and death in older adults.
- Africa faces a growing burden of coagulation abnormalities due to demographic and disease trends.
Purpose of the Study:
- To highlight the challenges in diagnosing and managing coagulation disorders in elderly Africans.
- To assess the role and availability of key coagulation biomarkers in African healthcare settings.
- To explore the potential of emerging biomarkers for improved patient assessment.
Main Methods:
- Review of current literature on coagulation disorders in the elderly.
- Analysis of the impact of demographic shifts and disease prevalence in Africa.
- Evaluation of the utility and accessibility of standard coagulation tests (e.g., D-dimer, PT, aPTT, platelet indices).
Main Results:
- Coagulation disorders present a significant, under-recognized challenge in aging African populations.
- Standard diagnostic tools for coagulation disorders are inconsistently available and utilized in Africa.
- Limited resources and data impede effective risk stratification and timely intervention.
Conclusions:
- There is a critical need to improve the recognition and management of coagulation disorders in elderly Africans.
- Enhanced accessibility and utilization of diagnostic biomarkers are essential.
- Further research into emerging biomarkers may offer improved diagnostic capabilities.
Abstract:
The global increase in life expectancy has brought aging-related health challenges to the forefront, with coagulation disorders emerging as a significant cause of morbidity and mortality among the elderly. In Africa, the burden of coagulation abnormalities is becoming increasingly evident due to demographic shifts, the rising prevalence of noncommunicable diseases, and the persistent impact of infectious diseases that affect coagulation pathways. Despite this growing challenge, limited data and constrained healthcare resources hinder effective recognition and management of these conditions. Biomarkers such as D-dimer, prothrombin time, activated partial thromboplastin time, and platelet indices play a crucial role in diagnosing and monitoring coagulation disorders in elderly patients. However, the availability and utilization of these diagnostic tools remain inconsistent across African healthcare settings, limiting timely risk stratification and intervention. Emerging biomarkers offer potential for improved assessment.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacodynamics in Geriatric Patients: Effects of Age

